CAAS Capital Management’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,650
Closed -$415K 1068
2022
Q2
$415K Buy
+41,650
New +$413K 0.02% 565
2021
Q3
Sell
-100,000
Closed -$980K 1297
2021
Q2
$980K Hold
100,000
0.02% 565
2021
Q1
$969K Buy
+100,000
New +$966K 0.01% 812

CAAS Capital Management's ISLE Position: Q3 2022 in Review

CAAS Capital Management sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 41,650 shares — an estimated $415K sold.

CAAS Capital Management first reported a position in ISLE in Q1 2021 and held it in 3 quarters. The position peaked at $980K in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • CAAS Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • CAAS Capital Management sold 41,650 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $415K.
  • CAAS Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 3 quarters.
  • CAAS Capital Management's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $980K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on CAAS Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.